Arcadia Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $11.2M | $24.0M | $12.0M |
| FY2019 | $24.2M | $32.6M | $8.4M |
| FY2020 | $18.8M | $47.3M | $14.0M |
| FY2021 | $12.7M | $43.9M | $28.7M |
| FY2022 | $8.0M | $28.9M | $20.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $11.2M | $24.0M | $12.0M |
| FY2019 | $24.2M | $32.6M | $8.4M |
| FY2020 | $18.8M | $47.3M | $14.0M |
| FY2021 | $12.7M | $43.9M | $28.7M |
| FY2022 | $8.0M | $28.9M | $20.6M |